Retention and Re-Engagement in Treatment for Addiction Following Serious Injection Related Infections (RETAIN)
Key facts
- Who runs it
- Boston Medical Center
- Where
- Boston, United StatesSee the site
- Trial code
- Status
- Completed
- People taking part
- 40 people enrolled
- Started
- 6 Jan 2025
- Ended
- 11 May 2026
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- RETAIN
- Unrelated videos
- Record updated
- 2 July 2026
Who can take part
- Age
- 18 years to 65 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 9 criteriaShow less
Who can take part
- Between 18 and 65 years of age
- Able to provide Informed Consent
- Admitted to Boston Medical Center on any inpatient unit for an active serious injection related infection (SIRI) such as endocarditis, osteomyelitis, bacteremia, septic arthritis, epidural abscess or other serious infection in which two weeks or more of antibiotics are recommended
Who cannot take part
- Not able to give informed consent
- Cognitive ability (defined through Research Assistant (RA) determination)
- Inability to complete assessments in English or Spanish (defined through RA determination)
- Exclusion for any reason under PI discretion
- Unable to provide names and contact information for at least two verifiable locator persons who will know where to find them in the future
- In police custody or expecting incarceration
Where in United States
- Boston Medical CenterBoston, United States
About the trial
What the trial wants to find out
This project is a pilot study of an adapted intervention of an existing Opioid Use Disorder (OUD) treatment retention intervention called Recovery Management Checkups (RMC). This intervention has been adapted to better fit the experiences and unique issues of those that have been hospitalized with serious injection related infections (SIRI) based on the findings from a prior qualitative study from the principal investigator. This project plans to test the adapted intervention within a smaller group of participants to assess feasibility, acceptability, and calculate early findings of intervention efficacy.
Read full original descriptionShow less
Hospitalizations for SIRIs are a unique entry point for patients to start their recovery journey with medications for OUD (MOUD), but many people do not remain on long-term treatment, despite evidence that indicates MOUDs reduce death and re-hospitalization after SIRIs.
The study objectives are to:
* Assess the implementation feasibility of the adapted RMC model for patients with SIRI and OUD. * Establish preliminary estimates of intervention efficacy. * Make further adaptions to the intervention that will reduce both known and unknown barriers to care and increase effectiveness in future larger scale trials.
Findings from this pilot study will result in further intervention refinement to better fit the target population, and serve as the basis for a larger randomized control trial that will have aims focused on more in-depth analysis of the efficacy of this program
The 2 groups in the trial
- RETAIN interventionTreatment being tested
Participants randomized to the RETAIN intervention will receive Motivational Interviewing targeted to their clinical concerns and personalized support tailored to each participants' specific needs determined by their answers to intake questions.
Treatment: RETAIN
- ControlExisting treatment, for comparison
Control arm participants will be offered different videos or podcast episodes that are unrelated to the study topics of infections, substance use, overdose, and medication management.
Treatment: Unrelated videos
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Retention and Re-Engagement in Treatment for Addiction Following Serious Injection Related Infections (RETAIN): A Pilot Randomized Controlled Study
- Record updated
- 2 July 2026